Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.60 |
| ▸ | SQLE | Q14534 | 7/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.50 |
| ▸ | FNTB | P49356 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332318 | 1.00 | KMT2A (0.68) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL3503739 | 1.00 | KMT2A (0.68) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL12555811 | 0.98 | KMT2A (0.73) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL331851 | 0.98 | KMT2A (0.73) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL12412583 | 0.98 | KMT2A (0.73) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL296281 | 0.98 | KMT2A (0.73) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL3791172 | 0.98 | KMT2A (0.73) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL8064939 | 0.83 | KMT2A (0.73) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Squalene SCHEMBL28619973 | 0.83 | KMT2A (0.81) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Squalene SCHEMBL28619974 | 0.83 | KMT2A (0.81) | KMT2AMEN1CYP3A4ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| US-20230151305-A1 | FRAGRANCE COMPOSITION | SA, GIVAUDAN (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4146778-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2023-03-15 | — | — | EP | claimed |
| US-11364184-B2 | Perfume compositions | GIVAUDAN SA (CH) | 2022-06-21 | — | — | US | claimed |
| WO-2021224201-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2021-11-11 | — | — | WO | claimed |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | PROCTER & GAMBLE (US) | 2020-05-14 | — | — | US | claimed |
| US-10568825-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-02-25 | — | — | US | claimed |
| US-20170267944-A1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-09-21 | — | — | US | claimed |
| EP-3139902-A2 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2017-03-15 | — | — | EP | claimed |
| WO-2015171738-A2 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-12 | — | — | WO | claimed |
| EP-2931235-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931854-A1 | FRAGRANCE MATERIALS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| US-20140179748-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| WO-2014093828-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093748-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMAPNY (US) | 2014-06-19 | — | — | US | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-3996387-A | Flavoring with 3,7-dimethyl-octa-2,6-dienyl-mercaptan | GIVAUDAN CORPORATION (US) | 1976-12-07 | — | — | US | claimed |
| US-3975311-A | 3,7-Dimethyl-octa-2,6 dienyl-mercaptan perfume composition | GIVAUDAN CORPORATION (US) | 1976-08-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | KMT2A 2244/4885MEN1 3398/4885CYP3A4 212/4885 |
| US-10568825-B2 | Antiperspirant and deodorant compositions | DEK, QDPR, GPX4 | KMT2A 2997/4885MEN1 4563/4885CYP3A4 557/4885 |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | KMT2A 2997/4885MEN1 4563/4885CYP3A4 557/4885 |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | KMT2A 2997/4885MEN1 4563/4885CYP3A4 557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.